SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
Back

Weight Loss

Published: Feb 6, 2025

Share

Tirzepatide dosage 101: All you need to know for weight loss

Share

Written by Klarity Editorial Team

Medically Reviewed by Dr. Sheelu Bhatnagar

Published: Feb 6, 2025

Tirzepatide dosage 101: All you need to know for weight loss
Table of contents
Share

Key takeaway: Tirzepatide for weight loss follows a gradual titration schedule starting at 2.5 mg/week and increasing every 4 weeks to a maximum of 15 mg/week. Slow titration minimizes side effects and improves tolerability. Most patients reach their maintenance dose within 5–7 months.

Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →

Tirzepatide is the active ingredient in 2 brand-name medications — Mounjaro and Zepbound. If you’re taking either and hope to lose weight, using the right dose matters. Here, we give you a 101 on tirzepatide dosage for weight loss.

Tirzepatide Dose-by-Dose: Side Effects & Management

Dose LevelTypical TimelineCommon Side EffectsManagement Strategies
2.5 mg/weekWeeks 1–4 (start)Mild nausea, decreased appetiteSmall meals; avoid high-fat foods; stay hydrated
5 mg/weekWeeks 5–8Nausea, mild diarrhea or constipationSmall portions; time injection on lighter-meal days
7.5 mg/weekWeeks 9–12Nausea, fatigue, possible vomitingGinger tea; rest after injection; avoid lying flat post-meal
10 mg/weekMonths 4–5GI symptoms, possible muscle achesElectrolyte support; light exercise; provider check-in
12.5 mg/weekMonths 5–6GI symptoms, injection-site reactionsRotate injection sites; maintain hydration
15 mg/week (max)Month 7+GI symptoms stabilize; hair thinning possibleAdequate protein intake; follow up with provider

About tirzepatide

Mounjaro and Zepbound are the only available forms of FDA-approved tirzepatide. Tirzepatide is a combination GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) agonist. The dual action stimulates the pancreas to secrete insulin and slows gastric emptying, making you feel full and reducing appetite. In 2 different clinical trials, people taking tirzepatide lost 12.8 to 20.9% of their body weight in 72 weeks.

Available tirzepatide dosages

Mounjaro and Zepbound are available in the same 6 dosages: 2.5, 5, 7.5, 10, 12.5, and 15 milligrams per 0.5 milliliters, each in a prefilled single-dose pen. One dose is taken each week; a month’s supply requires 4 pens.

From starting to maintenance tirzepatide dosage

Zepbound and Mounjaro follow a stepped dosing schedule. You start at a low dose so your body can adjust, then increase every 4 weeks until reaching a maintenance dose. The target maintenance dose for Zepbound is typically 15 mg, where clinical studies show the greatest weight loss. Your provider may adjust the schedule if side effects arise — for example, increasing every 8 weeks rather than 4.

Tirzepatide dosage chart (Mounjaro vs Zepbound)

WeeksZepbound doseMounjaro dose
Weeks 1–42.5 mg2.5 mg
Weeks 5–85 mg5 mg
Weeks 9–127.5 mg7.5 mg
Weeks 13–1610 mg10 mg
Weeks 17–2012.5 mg12.5 mg
Weeks 21+15 mg (max)15 mg (max)

GLP-1 Medications in 2026: What’s New

The GLP-1 landscape has expanded significantly entering 2026, offering patients more options and broader access than ever before.

  • Tirzepatide expanded indications: Following FDA approvals in 2024–2025, tirzepatide (Zepbound/Mounjaro) has expanded labeling covering additional cardiovascular and metabolic indications.
  • Oral semaglutide for weight loss: Rybelsus (oral semaglutide) is seeing growing uptake for weight management as patients seek needle-free GLP-1 options.
  • Triple agonists on the horizon: Retatrutide has shown striking Phase 3 results and may reach the market in 2026–2027.
  • Insurance coverage expansion: Ongoing discussions around the Treat and Reduce Obesity Act are pushing toward broader Medicare and Medicaid coverage. Coverage varies by plan. Verify your benefits before booking.
  • Compounded GLP-1 changes: The FDA’s stance on compounded tirzepatide shifted throughout 2025. Always confirm regulatory status with your provider.
  • Telehealth access expanding: Platforms like Klarity offer same-day access to 2,000+ licensed providers.

How to get a prescription for Zepbound or Mounjaro

To get a prescription for tirzepatide, you need to speak with a licensed healthcare provider — such as an MD, nurse practitioner, or physician assistant. You can do that in-office or online through a healthcare marketplace, including Klarity Health. Your provider can determine if a weight loss medication is appropriate, obtain prior authorization if needed, and monitor your progress throughout your treatment.

Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →

Frequently Asked Questions

What are GLP-1 medications?

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) reduce appetite, slow digestion, and support blood sugar regulation. They are widely used for weight management and type 2 diabetes.

How do I get a prescription for tirzepatide or semaglutide?

A licensed provider must evaluate your health history and BMI. Through Klarity, you can complete this entirely online with same-day appointments.

Will my insurance cover GLP-1 medications?

Many commercial plans may cover GLP-1 medications for obesity or metabolic conditions. Coverage varies by plan. Verify your benefits before booking.

How are side effects typically managed?

Most GLP-1 side effects are dose-dependent and manageable through slow titration, dietary adjustments, and hydration. Your Klarity provider can personalize a management plan for you.

How can Klarity help with my GLP-1 treatment?

Klarity’s 2,000+ licensed providers can evaluate your eligibility, prescribe GLP-1 medications if appropriate, and help you manage side effects — all online. See if you may qualify →

Looking for support with Weight loss? Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.